# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-232857
Filing Date
2026-05-20
Accepted
2026-05-20 17:22:39
Documents
84
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sclx-20260331.htm iXBRL | 10-Q | 4198897
2 | EX-4.21 | sclx-ex4_21.htm | EX-4.21 | 104766
3 | EX-10.2 | sclx-ex10_2.htm | EX-10.2 | 90581
4 | EX-10.3 | sclx-ex10_3.htm | EX-10.3 | 623239
5 | EX-31.1 | sclx-ex31_1.htm | EX-31.1 | 14510
6 | EX-31.2 | sclx-ex31_2.htm | EX-31.2 | 14003
7 | EX-32.1 | sclx-ex32_1.htm | EX-32.1 | 13951
| Complete submission text file | 0001193125-26-232857.txt |  | 21029490

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | sclx-20260331.xsd | EX-101.SCH | 3204496
88 | EXTRACTED XBRL INSTANCE DOCUMENT | sclx-20260331_htm.xml | XML | 3547303

Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39852 | Film No.: 261005154
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)